EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Siegfried Holding AG's enterprise value is CHF3,735 Mil.
Siegfried Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF241 Mil. Therefore, Siegfried Holding AG's EV-to-EBITDA for today is 15.50.
The historical rank and industry rank for Siegfried Holding AG's EV-to-EBITDA or its related term are showing as below:
XSWX:SFZN'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.55 Med: 12.01 Max: 28.38
Current: 15.49
During the past 13 years, the highest EV-to-EBITDA of Siegfried Holding AG was 28.38. The lowest was 5.55. And the median was 12.01.
XSWX:SFZN's EV-to-EBITDA is ranked worse than 52.19% of 707
companies
in the Drug Manufacturers industry
Industry Median: 14.79
vs XSWX:SFZN: 15.49
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Siegfried Holding AG EV-to-EBITDA Historical Data
The historical data trend for Siegfried Holding AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Siegfried Holding AG's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siegfried Holding AG's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Siegfried Holding AG's EV-to-EBITDA falls into.
Siegfried Holding AG's current Enterprise Value is CHF3,735 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Siegfried Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF241 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siegfried Holding AG (XSWX:SFZN) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Siegfried Holding AG's PE Ratio for today is calculated as:
Siegfried Holding AG's share price for today is CHF884.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Siegfried Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF26.220.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Siegfried Holding AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Siegfried Holding AG (XSWX:SFZN) Business Description
Siegfried Holding AG is a biotechnology company that focuses on primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. The company broadly offers complex oral and sterile formulations of drug products available for custom development and manufacturing, as well as licensing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XSWX:SFZN has been successfully added to your 